Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and development, announced Najat Khan, PhD, will be its Chief R&D Officer and Chief Commercial Officer. Dr. Khan will lead Recursion’s research and development, and build its emerging commercial capabilities. She has also been appointed to Recursion’s Board of Directors.

“Najat brings a unique blend of leadership in biological, chemical, and medical sciences, data science, and business,” said Chris Gibson, Co–Founder and CEO of Recursion. “More importantly, she has a vision and passion for transforming drug discovery and development that complements ours and she has a strong sense of urgency to accelerate the industry’s future. We are excited to welcome her as a Recursionaut to drive our portfolio pipeline, as well as create commercial strategies as we continue to industrialize the creation of high impact medicines.”

Dr. Khan has deep expertise in the pharmaceutical and healthcare industry, spanning biological, chemical, and medical science, computational and data science, and general business leadership, with a focus on driving substantial patient and business value. As the Chief Data Science Officer and Global Head of Strategy and Portfolio Organization, for Innovative Medicine R&D at Johnson & Johnson, Najat played an integral role with the senior leadership team in building an industry–leading pipeline that delivered multiple transformational medicines. She has been a pioneer in driving the impact of data science/AI at scale while establishing a top–tier diverse data science team, underpinning her commitment to innovation and excellence at the intersection of healthcare and technology. Dr. Khan co–chaired Johnson & Johnson’s Data Science Council, where she has played a key leadership role in driving the adoption of data science across the company to achieve business impact and deploy best practices for data use, AI, ethics, as well talent recruitment and development.

“My mission and focus has been to harness the power of science, data, and AI to revolutionize the way we discover, develop, and deliver transformative medicines for patients”, said Dr. Khan, “This seamlessly aligns with Recursion’s goal to pioneer the burgeoning TechBio sector and decode biology and chemistry to radically improve lives. I believe their approach represents the future of our industry, and sets Recursion to be at the forefront to deliver on this vision. I’m thrilled to be part of Recursion’s board and leadership team, embarking on this vital mission together.”

Dr. Khan serves as a board member for Alliance for Artificial Intelligence in Healthcare and is a Steering Committee member of the White House’s Moonshot CancerX program to enhance outcomes for cancer patients. Najat is the founder and co–chair of the Data Science in Industry Roundtable (DISRUPT) – a cross industry forum dedicated to driving impact through Data Science. She is an alumna of University of Pennsylvania with a doctorate in Organic Chemistry leveraging experimental and computational approaches, has an undergraduate degree in Computational Chemistry and a minor in Business / Economics from Colgate University, and is published in various high–impact journals.

“We are pleased to welcome Najat to the board to guide the strategic vision of Recursion,” said Dean Li, Co–Founder and Board Member of Recursion and President, Merck Research Laboratories, “Najat shares our outlook on how the industry needs to evolve, and I believe her insight will be highly valuable as we enter the era of AI enabled drug discovery and development.”

About Recursion
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient–centric datasets. Recursion leverages sophisticated machine–learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, chemistry and patient–centric data to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Media Contact
Media@Recursion.com

Investor Contact
Investor@Recursion.com

Forward–Looking Statements
This document contains information that includes or is based upon “forward–looking statements” within the meaning of the Securities Litigation Reform Act of 1995, including, without limitation, all statements that are not historical facts. Forward–looking statements may or may not include identifying words such as “plan,” “will,” “expect,” “anticipate,” “intend,” “believe,” “potential,” “continue,” and similar terms. These statements are subject to known or unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements, including but not limited to: challenges inherent in pharmaceutical research and development, including the timing and results of preclinical and clinical programs, where the risk of failure is high and failure can occur at any stage prior to or after regulatory approval due to lack of sufficient efficacy, safety considerations, or other factors; our ability to leverage and enhance our drug discovery platform; our ability to obtain financing for development activities and other corporate purposes; the success of our collaboration activities; our ability to obtain regulatory approval of, and ultimately commercialize, drug candidates; our ability to obtain, maintain, and enforce intellectual property protections; cyberattacks or other disruptions to our technology systems; our ability to attract, motivate, and retain key employees and manage our growth; inflation and other macroeconomic issues; and other risks and uncertainties such as those described under the heading “Risk Factors” in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10–K. All forward–looking statements are based on management’s current estimates, projections, and assumptions, and Recursion undertakes no obligation to correct or update any such statements, whether as a result of new information, future developments, or otherwise, except to the extent required by applicable law.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/21f011ab–bada–4c3e–a55f–d8eabecf35ad


GLOBENEWSWIRE (Distribution ID 9090097)

eXp Realty Nomeia Leo Pareja para CEO para Impulsionar a Próxima Era de Crescimento e Inovação

BELLINGHAM, Wash., April 06, 2024 (GLOBE NEWSWIRE) — A eXp Realty®, “the most agent–centric real estate brokerage on the planet™” e a principal subsidiária da eXp World Holdings, Inc. (Nasdaq: EXPI), anunciou hoje a nomeação de Leo Pareja para novo Diretor Executivo (CEO), com efeito imediato. Ele sucede Glenn Sanford, que agora dedicará totalmente seus esforços ao cargo de Fundador, Presidente e CEO da eXp World Holdings.

Na sua função anterior de Diretor de Estratégia, Pareja foi fundamental para solidificar a posição da eXp Realty no competitivo mercado imobiliário. Sua liderança visionária e histórico notável enriqueceram muito a proposta de valor da empresa para seus agentes. Por exemplo, os lançamentos bem–sucedidos de iniciativas estratégicas como eXp Exclusives, Revenos e as melhorias significativas para eXp Solutions.

“A liderança inovadora e reconhecida de Leo no setor elevou nossa proposta de valor para os agentes, reformulando as referências e a geração de leads”, disse Sanford. “Sua profunda experiência no setor e influência na nossa comunidade são profundas, e confio que, sob sua direção, a eXp Realty fortalecerá ainda mais sua vantagem competitiva e oferecerá um valor incomparável aos nossos agentes, consolidando ainda mais nossa posição de líder inovador no setor imobiliário.”

Esta nomeação se dá no momento em que a eXp Realty está em primeiro lugar em cinco categorias do cobiçado relatório RealTrends 500: Transaction Sides, 5 Year Top Movers (Sides), 5 Year Top Movers (Volume), Best Brokerages e Public Independent. A empresa também subiu para o número 3 em duas categorias: Volume e Billionaires’ Club. A empresa continua a provar seu modelo à medida que ganha participação de mercado, recebendo os melhores agentes do setor.

“Ao entrarmos neste novo capítulo da eXp Realty, tenho a honra de liderar uma empresa que sempre colocou a inovação e o sucesso dos agentes na vanguarda da sua missão”, disse Pareja. “Juntos, além de continuarmos a redefinir o cenário imobiliário por meio da tecnologia e do suporte incomparável aos agentes, também capacitaremos todos os membros da nossa comunidade a atingir todo o seu potencial.”

Quando ingressou na eXp Realty em 2022, Pareja trouxe consigo mais de duas décadas de experiência imobiliária, destacada por inúmeras premiações, incluindo reconhecimento no relatório The Thousand da RealTrends, liderando a lista Top 250 da National Association of Hispanic Real Estate Professionals (NAHREP) e sendo nomeado um agente 30 abaixo de 30 pela Realtor® Magazine. Seu espírito empreendedor é evidenciado pela sua cofundação de uma das maiores empresas privadas de empréstimos na Costa Leste dos EUA e um fornecedor de tecnologia MLS em rápido crescimento. Ele também desempenhou papéis significativos na National Association of Hispanic Real Estate Professionals, atuando como presidente fundador da filial de Metro D.C. e mais tarde como presidente nacional.

Sobre a eXp World Holdings, Inc.
A eXp World Holdings, Inc. (Nasdaq: EXPI) é a holding da eXp Realty®, Virbela® e SUCCESS® Enterprises. eXp Realty é a maior empresa imobiliária independente do mundo, com mais de 85.000 agentes nos Estados Unidos, Canadá, Reino Unido, Austrália, França do, Índia, México, Portugal, África do Sul, Porto Rico, Brasil, Itália, Hong Kong, Colômbia, Espanha, Israel, Panamá, Alemanha, República Dominicana, Grécia, Nova Zelândia, Chile, Polônia e Dubai além de continuar a crescer em todo o mundo. Uma empresa de capital aberto, a eXp World Holdings oferece aos profissionais do setor imobiliário a oportunidade única de receber prêmios de capital por metas de produção e contribuições para o crescimento geral da Empresa. A eXp World Holdings e suas empresas oferecem um conjunto completo de soluções tecnológicas de corretagem e imobiliária, incluindo seu inovador modelo de corretagem residencial e comercial, serviços profissionais, ferramentas colaborativas e desenvolvimento pessoal. A corretora na nuvem tem por base as tecnologias Virbela e Frame, oferecendo plataformas 3D imersivas profundamente sociais e colaborativas, que permitem que os agentes sejam mais conectados e produtivos. A SUCCESS® Enterprises, ancorada pela revista SUCCESS® e seus ativos de mídia, foi fundada em 1897 e é uma marca e publicação líder em desenvolvimento pessoal e profissional.

Para mais informação, visite https://expworldholdings.com.    

Contato de Relações com a Mídia:
eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Contato de Relações com Investidores:
Denise Garcia
investors@expworldholdings.com

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/c0430659–d8bc–480b–8eeb–02408802c697


GLOBENEWSWIRE (Distribution ID 9085604)

eXp Realty nomme Leo Pareja au poste de PDG pour mener la prochaine ère de croissance et d’innovation de l’entreprise

BELLINGHAM, Wash, 06 avr. 2024 (GLOBE NEWSWIRE) — eXp Realty®, « la société de courtage immobilier la plus centrée au monde sur les agents™ » et une filiale principale d’eXp World Holdings, Inc. (Nasdaq : EXPI), a annoncé aujourd’hui la nomination de Leo Pareja au poste de PDG, avec effet immédiat. Il succède à Glenn Sanford, qui se consacrera désormais pleinement à son poste de fondateur, président et PDG d’eXp World Holdings.

Dans ses précédentes fonctions de directeur de la stratégie, M. Pareja a contribué à consolider la position d’eXp Realty sur le marché concurrentiel de l’immobilier. Son leadership visionnaire et ses résultats remarquables ont considérablement enrichi la proposition de valeur de l’entreprise auprès de ses agents. Par exemple, le lancement réussi d’initiatives stratégiques telles que Exclusivités eXpRevenos et les améliorations significatives apportées aux Solutions eXp.

« Le leadership innovant et reconnu de Leo dans le secteur a permis d’améliorer notre proposition de valeur pour les agents en remodelant les références et la génération d’opportunités », a déclaré M. Sanford. « Sa grande expérience du secteur et son influence sur notre communauté ont été profondes, et je suis convaincu que sous sa direction, eXp Realty renforcera encore un peu plus son avantage concurrentiel et offrira une valeur inégalée à ses agents, consolidant ainsi notre position de leader révolutionnaire dans le secteur de l’immobilier. »

Cette annonce intervient alors qu’eXp Realty est reconnue aux premières places du podium des cinq catégories du très convoité rapport RealTrends 500 : « Transaction Sides », « 5 Year Top Movers (Sides) », « 5 Year Top Movers (Volume) », « Best Brokerages » et « Public Independent ». L’entreprise s’est également hissée à la troisième place dans deux catégories : « Volume » et « Billionaires’ Club ». L’entreprise continue de démontrer la pertinence de son modèle en gagnant des parts de marché et en accueillant les meilleurs agents du secteur.

« Alors que nous entamons l’écriture d’un nouveau chapitre chez eXp Realty, je suis honoré de diriger une entreprise qui a toujours placé l’innovation et la réussite des agents au premier plan de sa mission », a déclaré M. Pareja. « Ensemble, nous allons non seulement continuer à redéfinir le paysage immobilier grâce à la technologie et à un soutien inégalé aux agents, mais aussi donner à chaque membre de notre communauté les moyens de réaliser son plein potentiel. »

M. Pareja a rejoint les rangs d’eXp Realty en 2022 et apporte avec lui plus de deux décennies d’expérience dans l’immobilier, illustrées par de nombreuses récompenses, y compris la reconnaissance dans le rapport « The Thousand de RealTrends », en se classant en tête de la liste « Top 250 » de la National Association of Hispanic Real Estate Professionals (« NAHREP ») et en étant nommé ans la liste « 30 under 30 agent » par Realtor® Magazine. Son esprit d’entreprise est illustré par le fait qu’il a cofondé l’une des plus grandes sociétés de prêts privés de la côte est des États–Unis et un fournisseur de technologie MLS en pleine expansion. Il a également joué un rôle important au sein de la National Association of Hispanic Real Estate Professionals, en tant que président fondateur de la division de la région métropolitaine de Washington et, plus tard, en tant que président national.

À propos d’eXp World Holdings, Inc.
eXp World Holdings, Inc. (Nasdaq : EXPI) est la société holding d’eXp Realty®, Virbela® et SUCCESS® Enterprises. eXp Realty est la plus grande société immobilière indépendante au monde. eXp Realty recense plus de 85 000 agents aux États–Unis, au Canada, au Royaume–Uni, en Australie, en France, en Inde, au Mexique, au Portugal, en Afrique du Sud, à Porto Rico, au Brésil, en Italie, à Hong Kong, en Colombie, en Espagne, en Israël, au Panama, en Allemagne, en République dominicaine, en Grèce, en Nouvelle–Zélande, au Chili, en Pologne et à Dubaï, et continue de se développer à l’échelle internationale. Cotée en Bourse, la société eXp World Holdings offre aux professionnels de l’immobilier l’opportunité unique de se voir attribuer des actions pour récompenser les objectifs de production et leurs contributions à la croissance globale de l’entreprise. eXp World Holdings et ses entités proposent une gamme complète de solutions technologiques de courtage et d’immobilier, notamment un modèle innovant de courtage résidentiel et commercial, des services aux entreprises, des outils de collaboration et du développement personnel. La société de courtage basée sur le cloud est alimentée par Virbela et les technologies Frame, offrant une plateforme 3D immersive profondément sociale et collaborative qui permet aux agents d’être plus connectés et plus productifs. Ancrée dans le paysage grâce à la notoriété du magazine SUCCESS® et de ses activités média connexes, la marque et publication SUCCESS® Enterprises, créée en 1897, se place en chef de file du développement personnel et professionnel.

Pour plus d’informations, consultez https://expworldholdings.com.    

Contact relations avec les médias :
eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Contact relations investisseurs :
Denise Garcia
investors@expworldholdings.com

Une photo accompagnant ce communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/c0430659–d8bc–480b–8eeb–02408802c697


GLOBENEWSWIRE (Distribution ID 9085604)

eXp Realty ernennt Leo Pareja zum CEO, um die nächste Ära von Wachstum und Innovation voranzutreiben

BELLINGHAM, Washington, April 06, 2024 (GLOBE NEWSWIRE) — eXp Realty®, „the most agent–centric real estate brokerage on the planet™“ (das am stärksten auf Makler ausgerichtete Immobilienvermittlungsunternehmen der Welt) und wichtigste Tochtergesellschaft von eXp World Holdings, Inc. (Nasdaq: EXPI), gab heute die Ernennung von Leo Pareja zum neuen Chief Executive Officer (CEO) des Unternehmens mit sofortiger Wirkung bekannt. Er tritt die Nachfolge von Glenn Sanford an, der sich nun voll und ganz seiner Position als Gründer, Vorsitzender und CEO von eXp World Holdings widmen wird.

In seiner vorherigen Funktion als Chief Strategy Officer war Pareja maßgeblich an der Festigung der Position von eXp Realty auf dem wettbewerbsintensiven Immobilienmarkt beteiligt. Seine visionäre Führung und seine bemerkenswerte Erfolgsbilanz haben das Nutzenversprechen des Unternehmens gegenüber seinen Maklern erheblich bereichert. Beispielhaft seien die erfolgreiche Einführung von strategischen Initiativen wie eXp Exclusives und Revenos sowie wesentliche Verbesserungen der eXp Solutions genannt.

„Leos innovative und anerkannte Führungsrolle in der Branche hat unser Angebot für Makler verbessert, indem wir die Empfehlungspraxis und Lead–Generierung neu gestaltet haben“, so Sanford. „Ich bin zuversichtlich, dass eXp Realty unter seiner Leitung seinen Wettbewerbsvorteil weiter ausbauen und unseren Maklern einen unvergleichlichen Mehrwert bieten wird, was unsere Position als bahnbrechendes führendes Unternehmen in der Immobilienbranche weiter festigen wird.“

Die Ankündigung erfolgt zu einem Zeitpunkt, zu dem eXp Realty in fünf Kategorien des RealTrends 500–Berichts auf den begehrten ersten Plätzen zu finden ist: Transaction Sides, 5 Year Top Movers (Sides), 5 Year Top Movers (Volume), Best Brokerages und Public Independent. In zwei weiteren Kategorien ist das Unternehmen auf Platz 3 vorgerückt: Volume und Billionaires’ Club. Das Unternehmen stellt sein Modell weiterhin unter Beweis, indem sein Marktanteil wächst und es die besten Makler der Branche für sich gewinnt.

„Wir eröffnen ein neues Kapitel bei eXp Realty und ich fühle mich geehrt, ein Unternehmen zu leiten, für das Innovation und der Maklererfolg schon immer an erster Stelle standen“, so Pareja. „Gemeinsam werden wir nicht nur die Immobilienlandschaft durch Technologie und unvergleichliche Maklerunterstützung neu definieren, sondern auch jedes Mitglied unserer Gemeinschaft befähigen, sein volles Potenzial auszuschöpfen.“

Pareja ist seit 2022 bei eXp Realty und verfügt über mehr als zwei Jahrzehnte Erfahrung in der Immobilienbranche. Dies wird durch zahlreiche Auszeichnungen unterstrichen, darunter die Anerkennung im RealTrends–Bericht „The Thousand“, der erste Platz auf der Top 250–Liste der National Association of Hispanic Real Estate Professionals (NAHREP) und die Aufnahme in die Liste der „30 under 30“–Makler des Realtor® Magazine. Sein Unternehmergeist zeigt sich in der Mitbegründung eines der größten privaten Kreditunternehmen an der Ostküste der USA und eines schnell wachsenden Anbieters von MLS–Technologie. Außerdem spielte er eine wichtige Rolle in der National Association of Hispanic Real Estate Professionals, wo er als Gründungspräsident der Metro D.C. Chapter und später als nationaler Präsident fungierte.

Über eXp World Holdings, Inc.
eXp World Holdings, Inc. (Nasdaq: EXPI) ist die Holdinggesellschaft für eXp Realty®, Virbela® und SUCCESS® Enterprises. eXp Realty ist das größte unabhängige Immobilienunternehmen der Welt mit mehr als 85.000 Maklern in den Vereinigten Staaten, Kanada, dem Vereinigten Königreich, Australien, Frankreich, Indien, Mexiko, Portugal, Südafrika, Puerto Rico, Brasilien, Italien, Hongkong, Kolumbien, Spanien, Israel, Panama, Deutschland, der Dominikanischen Republik, Griechenland, Neuseeland, Chile, Polen und Dubai und expandiert weiter auf internationaler Ebene. Als börsennotiertes Unternehmen bietet eXp World Holdings Immobilienfachleuten die einzigartige Möglichkeit, für Produktionsziele und Beiträge zum Gesamtwachstum des Unternehmens Aktienprämien zu erhalten. eXp World Holdings und seine Geschäftsbereiche bieten ein umfassendes Angebot an Makler– und Immobilien–Technologielösungen, darunter ein innovatives Maklermodell für Wohn– und Gewerbeimmobilien, professionelle Dienstleistungen, Tools für die Zusammenarbeit und persönliche Entwicklung. Das cloudbasierte Maklerunternehmen wird von Virbela– und Frame–Technologien unterstützt, immersiven 3D–Plattformen, die stark sozial und kollaborativ ausgerichtet sind und es den Maklern ermöglichen, besser vernetzt sowie produktiver zu sein. SUCCESS® Enterprises, mit der Zeitschrift SUCCESS® und den dazugehörigen Medien, wurde 1897 gegründet und ist eine führende Marke und Publikation für persönliche und berufliche Entwicklung.

Weitere Informationen erhalten Sie unter https://expworldholdings.com.    

Pressekontakt:
eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Anlegerkontakt:
Denise Garcia
investors@expworldholdings.com

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/c0430659–d8bc–480b–8eeb–02408802c697


GLOBENEWSWIRE (Distribution ID 9085604)

eXp Realty Names Leo Pareja as CEO to Drive Next Era of Growth and Innovation

BELLINGHAM, Wash., April 05, 2024 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent–centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the appointment of Leo Pareja as its new Chief Executive Officer (CEO), effective immediately. He succeeds Glenn Sanford, who will now fully dedicate his efforts to his position as Founder, Chairman, and CEO of eXp World Holdings.

In his previous role as Chief Strategy Officer, Pareja was instrumental in solidifying eXp Realty's standing in the competitive real estate marketplace. His visionary leadership and remarkable track record has greatly enriched the company's value proposition to its agents. For example the successful launches of strategic initiatives like eXp Exclusives, Revenos and significant enhancements to eXp Solutions.

“Leo's innovative and recognized industry leadership has elevated our agent–value proposition by reshaping referrals and lead–generation,” said Sanford. “His deep industry experience and influence on our community have been profound, and I trust that under his direction, eXp Realty will further fortify its competitive advantage and deliver unparalleled value to our agents, further cementing our position as a ground–breaking leader in the real estate industry.”
The announcement comes as eXp Realty is recognized in the top spot in five categories on the coveted RealTrends 500 report: Transaction Sides, 5 Year Top Movers (Sides), 5 Year Top Movers (Volume), Best Brokerages and Public Independent. The company also moved up to No. 3 in two categories: Volume and Billionaires’ Club. The company continues to prove its model as it gains market share, welcoming the best agents in the industry.

“As we step into this new chapter at eXp Realty, I am honored to lead a company that has always placed innovation and agent success at the forefront of its mission,” said Pareja. “Together, we will not only continue to redefine the real estate landscape through technology and unparalleled agent support but also empower every member of our community to achieve their full potential.”

Having joined eXp Realty in 2022, Pareja brings over two decades of real estate experience, highlighted by numerous accolades including recognition in RealTrends’ The Thousand report, topping the National Association of Hispanic Real Estate Professionals’ (NAHREP) Top 250 list, and being named a 30 under 30 agent by Realtor® Magazine. His entrepreneurial spirit is evidenced by his co–founding of one of the largest private lending companies on the U.S. East Coast and a rapidly growing MLS technology vendor. He has also played significant roles in the National Association of Hispanic Real Estate Professionals, serving as the founding president of the Metro D.C. chapter and later as the national president.

About eXp World Holdings, Inc.
eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty®, Virbela® and SUCCESS® Enterprises. eXp Realty is the largest independent real estate company in the world with more than 85,000 agents in the United States, Canada, the United Kingdom, Australia, France, India, Mexico, Portugal, South Africa, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, the Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including an innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud–based brokerage is powered by Virbela and Frame technologies, offering immersive 3D platforms that are deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS® Enterprises, anchored by SUCCESS® magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com.    

Media Relations Contact:
eXp World Holdings, Inc.
mediarelations@expworldholdings.com

 

Investor Relations Contact:
Denise Garcia
investors@expworldholdings.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c0430659–d8bc–480b–8eeb–02408802c697


GLOBENEWSWIRE (Distribution ID 9085114)

KFSH&RC begrüßt Dr. Björn Zoéga als neuen stellvertretenden CEO

RIAD, Saudi–Arabien, April 03, 2024 (GLOBE NEWSWIRE) — Das King Faisal Specialist Hospital and Research Centre (KFSH&RC) freut sich, die Ernennung von Dr. Björn Zoéga zum stellvertretenden Chief Executive Officer (CEO) mit Wirkung vom 1. April 2024 bekanntzugeben. Mit dieser strategischen Ernennung möchte das KFSH&RC seinem Bestreben, eine weltweit führende Gesundheitseinrichtung zu werden, zusätzlichen Antrieb geben, indem es die bemerkenswerte Karriere von Dr. Zoéga und seine nachgewiesene Führungserfahrung in hochrangigen medizinischen Einrichtungen nutzt.

Als ehemaliger CEO des international renommierten Karolinska–Universitätskrankenhauses in Schweden spielte Dr. Zoéga eine entscheidende Rolle bei der Aufrechterhaltung der hohen Standards der Einrichtung und ihrer weltweiten Anerkennung als zweitbestes Krankenhaus in Europa und siebtbestes weltweit laut der von Newsweek herausgegebenen Rangliste der besten Krankenhäuser der Welt 2024. Seine Zeit im Karolinska–Krankenhaus war von innovativen Strategien und Spitzenleistungen in der Gesundheitsversorgung geprägt, die er im KFSH&RC weiter ausbauen möchte.

Dr. Zoéga bringt jahrzehntelange Erfahrung im Management des Gesundheitswesens und im klinischen Bereich in das KFSH&RC ein, nachdem er als CEO des Nationalen Universitätskrankenhauses von Island und des Stockholmer Wirbelsäulenzentrums an der Spitze der Einrichtungen stand. Sein Wissens– und Erfahrungsschatz in Forschung und Lehre, den er sich als früherer Präsident und Verwaltungsratsvorsitzender der EU–Gesellschaft für Halswirbelsäulenforschung und als Vorsitzender des wissenschaftlichen Beirats von Alvotech aneignen konnte, stellen eine zusätzliche Bereicherung dar.

In seiner Funktion als stellvertretender CEO wird Dr. Zoéga die Bereiche Gesundheitsversorgung sowie Forschung und Innovation des KFSH&RC leiten und damit das Engagement des Krankenhauses für die Integration weltweit bewährter Praktiken im Gesundheitswesen und die Förderung modernster medizinischer Forschung und Technologie fortsetzen.

Das KFSH&RC lädt die Gemeinschaft, Partner und Interessengruppen ein, Dr. Björn Zoéga willkommen zu heißen, und freut sich auf ein vielversprechendes neues Kapitel in der Gesundheitsversorgung, das eine bessere und gesündere Zukunft für alle fördern soll.

Für weitere Informationen kontaktieren Sie bitte:

Essam Al–Zahrani, Media Affairs Acting Head, 0555254429

Abdullah Al–Awn, Senior Media Editor, 0556294232

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e


GLOBENEWSWIRE (Distribution ID 9084058)

Le KFSH&RC accueille le Dr Björn Zoëga en tant que nouveau directeur général adjoint

RIYAD, Arabie saoudite, 03 avr. 2024 (GLOBE NEWSWIRE) — Le King Faisal Specialist Hospital and Research Centre (KFSH&RC) est fier d’annoncer la nomination du Dr Björn Zoëga au poste de directeur général adjoint, à compter du 1er avril 2024. Cette décision stratégique vise à accélérer l’aspiration du KFSH&RC à devenir un établissement de soins de santé de premier plan sur la scène mondiale, en s’appuyant sur la carrière remarquable du Dr Zoëga et ses antécédents avérés en matière de leadership dans des établissements médicaux de premier plan.

En tant qu’ancien directeur général de l’hôpital universitaire Karolinska de Suède, de renommée internationale, le Dr Zoëga a joué un rôle essentiel dans le maintien des normes élevées de l’établissement et de sa reconnaissance mondiale en tant que deuxième hôpital le mieux classé parmi les hôpitaux européens et septième au niveau mondial selon le classement de Newsweek des meilleurs hôpitaux du monde en 2024. Son administration à Karolinska a été marquée par des stratégies innovantes et l’excellence en termes de prestations de santé, autant d’éléments qu’il se propose d’enrichir au sein du KFSH&RC.

Le Dr Zoëga apporte au KFSH&RC des décennies d’expérience en gestion des soins de santé et d’expertise clinique, après avoir dirigé les opérations en tant que directeur général de l’hôpital universitaire national d’Islande et du Stockholm Spine Center. Son expérience et ses compétences en matière de recherche et d’éducation sont également inestimables, compte tenu de ses anciens rôles de président et de président du conseil d’administration de l’EU–Cervical Spine Research Society et de président du Conseil consultatif scientifique d’Alvotech.

En tant que directeur général adjoint, le Dr Zoëga dirigera les groupes de prestation de soins de santé et de recherche et d’innovation du KFSH&RC, conformément à l’engagement de l’hôpital d’intégrer les meilleures pratiques mondiales en matière de soins de santé et de poursuivre la recherche médicale et la technologie de pointe.

Le KFSH&RC invite la communauté, les partenaires et les parties prenantes à accueillir le Dr Björn Zoëga, tandis que l’établissement entame un nouveau chapitre prometteur dans le domaine des soins de santé, en s’engageant à favoriser un avenir plus brillant et plus sain pour tous.

Pour plus d’informations, veuillez contacter :

M. Essam Al–Zahrani, chef par intérim des affaires médiatiques, 0555254429

M. Abdullah Al–Awn, rédacteur en chef des médias, 0556294232

Une photo accompagnant ce communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e


GLOBENEWSWIRE (Distribution ID 9084058)

KFSH&RC Dá Boas-Vindas ao Novo CEO Adjunto Dr. Björn Zoéga

RIADE, Arábia Saudita, April 03, 2024 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) tem o orgulho de anunciar a nomeação do Novo CEO Adjunto Dr. Björn Zoéga em 1 de abril de 2024. Esse movimento estratégico deve acelerar o objetivo da KFSH&RC de se tornar uma instituição de saúde líder no cenário global, alavancando a notável carreira e o histórico comprovado de liderança do Dr. Zoéga em instituições médicas de primeira linha.

Como ex–CEO do internacionalmente renomado Karolinska University Hospital, na Suécia, o Dr. Zoéga desempenhou um papel fundamental na defesa dos altos padrões e do reconhecimento global da instituição como o segundo mais bem avaliado entre os hospitais europeus e o sétimo melhor do mundo, de acordo com o ranking da Newsweek dos Melhores Hospitais do Mundo 2024. Sua administração da Karolinska foi marcada por estratégias inovadoras e excelência na prestação de cuidados de saúde – tudo o que ele pretende aprimorar no KFSH&RC.

No KFSH&RC, o Dr. Zoéga irá utilizar suas décadas de gestão de saúde e experiência clínica, na liderança em operações como CEO do National University Hospital da Islândia e do Stockholm Spine Center. Sua experiência e competência em pesquisa e educação também são inestimáveis, como nas suas funções anteriores na qualidade de Presidente e Presidente do Conselho da Sociedade de Pesquisa da Coluna Cervical da UE e Presidente do Conselho Consultivo Científico da Alvotech.

Como CEO Adjunto, o Dr. Zoéga atuará como líder dos grupos de prestação de cuidados de saúde e pesquisa e inovação do KFSH&RC, seguindo o compromisso do hospital em integrar as melhores práticas globais em cuidados de saúde e buscar pesquisas e tecnologias médicas de ponta.

O KFSH&RC estende seu convite à comunidade, parceiros e partes interessadas a dar as boas–vindas ao Dr. Björn Zoéga, nesse novo capítulo promissor que a instituição embarca na área da saúde, comprometida em promover um futuro mais brilhante e saudável para todos.

Para mais informações, contate:

Sr. Essam Al–Zahrani, Dirigente Interino de Assuntos de Mídia, 0555254429

Sr. Abdullah Al–Awn, Editor Sênior de Mídia, 0556294232

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e 


GLOBENEWSWIRE (Distribution ID 9084058)

KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO

RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC's aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga's notable career and proven track record of leadership in top–tier medical institutions.

As the former CEO of the internationally renowned Karolinska University Hospital in Sweden, Dr. Zoéga played a pivotal role in upholding the institution’s high standards and global recognition as the second highest rated among European hospitals and seventh best worldwide according to Newsweek’s ranking of the World’s Best Hospitals 2024. His administration at Karolinska was marked by innovative strategies and excellence in healthcare delivery—all which he is posed to enrich within KFSH&RC.

Dr. Zoégabrings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center. His experience and faculties in research and education are also invaluable, given his former roles as President and Board Chairman of the EU–Cervical Spine Research Society and Chairman of the Scientific Advisory Board of Alvotech.

As Deputy CEO, Dr. Zoéga will serve as chief lead of KFSH&RC’s healthcare delivery and research and innovation groups, following on the hospital’s commitment to integrating global best practices in healthcare and pursuing cutting–edge medical research and technology.

KFSH&RC extends its invitation to the community, partners, and stakeholders to welcome Dr. Björn Zoéga, as the institution embarks on a promising new chapter in healthcare, committed to fostering a brighter and healthier future for all.

For more information, please contact:

Mr. Essam Al–Zahrani, Media Affairs Acting Head, 0555254429

Mr. Abdullah Al–Awn, Senior Media Editor, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e 


GLOBENEWSWIRE (Distribution ID 9083029)

Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 25, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the appointment of David Gee as Chief Marketing Officer (CMO). Mr. Gee brings more than 25 years of global sales and marketing expertise and will serve as a member of Cellebrite’s executive leadership team, reporting directly to CEO Yossi Carmil. He will oversee Cellebrite’s global marketing strategy and execution to help the Company capitalize on the major growth opportunities ahead in the digital investigations marketplace.

Mr. Gee joins Cellebrite as digital crimes escalate exponentially, and criminal activities become more sophisticated, requiring law enforcement and enterprises to apply more advanced tools to fully capture, manage and analyze all the digital evidence at their disposal. Cellebrite’s end–to–end Case–to–Closure (C2C) platform helps investigative teams in both public and private sectors reach time–to–evidence quicker and close cases faster, smarter and more defensibly than ever before.

“Cellebrite stands on the precipice of an unparalleled opportunity. As we forge ahead, scaling our extraordinary growth, we welcome aboard David Gee, a strategic marketing luminary,” said Yossi Carmil, Cellebrite CEO. “His seasoned expertise will propel our global expansion. David embodies our vision and champions the ethical and responsible use of technology, recognizing its power to safeguard our world. Together, we’ll redefine what’s possible.”

As a seasoned industry veteran, Mr. Gee brings a wealth of experience to his role as CMO. His previous roles have left indelible marks, and now he’s ready to propel Cellebrite to new heights. Most recently, he served as CMO at Coherent Inc. where he digitally transformed the business and was part of the management team that doubled the market capitalization within two years. Previously, David was CMO at Imperva, Zuora and Infoblox and held senior marketing and operational roles at Hewlett Packard, Yahoo!, Sun Microsystems and IBM.

“It is rare to find an opportunity that fits my personal values, while also aligning with my skill set. I am thrilled to join Cellebrite and become part of such an important, mission–based business,” said Mr. Gee. “Cellebrite’s achievements to date are inspiring, and the opportunities ahead to further accelerate justice are exciting. I look forward to working with my new colleagues as we focus on executing the programs, campaigns, and initiatives that will broaden market awareness and adoption of the Company’s innovative digital investigative solutions.”

To learn more about Cellebrite and its Case–to–Closure Platform, please visit www.cellebrite.com.

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigative platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on X at @Cellebrite.

References to Websites and Social Media Platforms
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

Caution Regarding Forward Looking Statements

This document includes “forward–looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward–looking statements include, but are not limited to, the following: helping our team further expand our business around the world; and executing the programs, campaigns and initiatives that will broaden market awareness of the Company’s innovative digital investigative solutions, fortify and expand our customer relationships globally, increase our market leadership and achieve our business objectives. Such forward–looking statements are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward–looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; failure to manage its growth effectively; Cellebrite’s ability to introduce new solutions and add–ons; its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e–commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite’s solutions; near term declines in new or renewed agreements; risks associated with inability to retain qualified personnel and senior management; the security of Cellebrite’s operations and the integrity of its software solutions; risks associated with the negative publicity related to Cellebrite’s business and use of its products; risks related to Cellebrite’s intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite’s operations in Israel, including the ongoing Israel–Hamas war and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti–corruption, trade compliance, anti–money–laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20–F filed with the SEC on March 21, 2024 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward–looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward–looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Media 

Victor Cooper 
Sr. Director of Corporate Communications + Content Operations 
Victor.cooper@cellebrite.com 
+1 404.804.5910 

Investor Relations 

Andrew Kramer 
Vice President, Investor Relations 
investors@cellebrite.com 
+1 973.206.7760

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dd321307–8ce5–4237–86b7–324ddbd27380


GLOBENEWSWIRE (Distribution ID 9078473)